Key points are not available for this paper at this time.
A major concern has recently emerged about a potential link between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and increased risk for suicidal ideation and behaviors based on International Classification of Diseases codes.
Tang et al. (Mon,) studied this question.